PA8806801A1 - Compuestos de amida como refuerzos de antivirales - Google Patents
Compuestos de amida como refuerzos de antiviralesInfo
- Publication number
- PA8806801A1 PA8806801A1 PA20088806801A PA8806801A PA8806801A1 PA 8806801 A1 PA8806801 A1 PA 8806801A1 PA 20088806801 A PA20088806801 A PA 20088806801A PA 8806801 A PA8806801 A PA 8806801A PA 8806801 A1 PA8806801 A1 PA 8806801A1
- Authority
- PA
- Panama
- Prior art keywords
- compounds
- reinforcements
- antiviral
- amida
- amida compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS QUE TIENEN PROPIEDADES INHIBIDORAS DE CYP450 Y POR LO TANTO SON ÚTILES COMO REFUERZOS DE DETERMINADAS DROGAS, ES DECIR, SON CAPACES DE AUMENTAR POR LO MENOS UNA DE LA VARIABLES FARMACOCINÉTICAS DE DETERMINADAS DROGAS CUANDO SE CO-ADMINISTRAN. LA INVENCIÓN PROPORCIONA ADEMÁS EL USO DE DICHOS COMPUESTOS COMO MEJORADORES DE LA BIODISPONIBILIDAD DE DETERMINADAS DROGAS. ADEMÁS SE PROPORCIOAN MÉTODOS PARA LA PREPARACIÓN DE LOS COMPUESTOS DE LA INVENCIÓN Y COMPOSICIONES FARMACÉUTICAS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122468 | 2007-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8806801A1 true PA8806801A1 (es) | 2009-07-23 |
Family
ID=39386111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20088806801A PA8806801A1 (es) | 2007-12-06 | 2008-12-05 | Compuestos de amida como refuerzos de antivirales |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US8350048B2 (es) |
| EP (1) | EP2235008B1 (es) |
| JP (1) | JP5509092B2 (es) |
| KR (1) | KR101624675B1 (es) |
| CN (1) | CN101878210B (es) |
| AP (1) | AP2804A (es) |
| AR (1) | AR069595A1 (es) |
| AU (1) | AU2008333165B2 (es) |
| BR (1) | BRPI0821021A2 (es) |
| CA (1) | CA2706155C (es) |
| CL (1) | CL2008003639A1 (es) |
| EA (1) | EA019616B1 (es) |
| HK (1) | HK1149553A1 (es) |
| IL (1) | IL205489A (es) |
| MX (1) | MX2010006166A (es) |
| MY (1) | MY151005A (es) |
| NZ (1) | NZ585652A (es) |
| PA (1) | PA8806801A1 (es) |
| PE (1) | PE20091263A1 (es) |
| TW (1) | TWI438202B (es) |
| UA (1) | UA103013C2 (es) |
| UY (1) | UY31513A1 (es) |
| WO (1) | WO2009071650A2 (es) |
| ZA (1) | ZA201004025B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0920809A2 (pt) * | 2008-10-07 | 2016-07-12 | Tibotec Pharm Ltd | compostos de amida como reforcos de antivirais |
| US20120172368A1 (en) * | 2009-09-03 | 2012-07-05 | Koen Vandyck | Bis-Benzimidazole Derivatives |
| US8759535B2 (en) | 2010-02-18 | 2014-06-24 | High Point Pharmaceuticals, Llc | Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof |
| MX339243B (es) | 2011-02-03 | 2016-05-18 | Vtv Therapeutics Llc | Derivados fusionados sustituidos de imidazol, composiciones farmaceuticas y metodos de uso de los mismos. |
| AU2012245524A1 (en) * | 2011-04-22 | 2013-10-24 | Merck Sharp & Dohme Corp. | Taste-masked formulations of raltegravir |
| WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
| CN104000824B (zh) * | 2014-05-28 | 2016-07-06 | 中山大学 | 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用 |
| WO2016089648A1 (en) | 2014-12-01 | 2016-06-09 | Vtv Therapeutics Llc | Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof |
| CN105985356B (zh) * | 2015-02-05 | 2018-06-22 | 四川大学 | 咪唑[2,1-b]噻唑衍生物及其制备方法和用途 |
| ES2893099T3 (es) | 2015-12-22 | 2022-02-08 | Kancera Ab | Acidos hidroxámicos bicíclicos útiles como inhibidores de la actividad de histona desacetilasa de mamíferos |
| AR114136A1 (es) | 2017-10-10 | 2020-07-29 | Hoffmann La Roche | Compuestos heterocíclicos |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037157A (en) * | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| AR037797A1 (es) | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | Combinacion de inhibidores de proteasa dependientes del citocromo p450 |
| MY142238A (en) * | 2002-03-12 | 2010-11-15 | Tibotec Pharm Ltd | Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| JP4879484B2 (ja) * | 2002-08-02 | 2012-02-22 | テイボテク・フアーマシユーチカルズ・リミテツド | 広スペクトルの２−アミノ−ベンゾチアゾールスルホンアミドｈｉｖプロテアーゼ阻害剤 |
| AR053845A1 (es) * | 2005-04-15 | 2007-05-23 | Tibotec Pharm Ltd | 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450 |
| CN101674822A (zh) | 2006-08-18 | 2010-03-17 | 塞阔伊亚药品公司 | 抑制细胞色素p450的组合物和方法 |
-
2008
- 2008-05-12 UA UAA201006463A patent/UA103013C2/uk unknown
- 2008-12-05 CA CA2706155A patent/CA2706155C/en active Active
- 2008-12-05 WO PCT/EP2008/066847 patent/WO2009071650A2/en active Application Filing
- 2008-12-05 JP JP2010536465A patent/JP5509092B2/ja not_active Expired - Fee Related
- 2008-12-05 BR BRPI0821021-7A patent/BRPI0821021A2/pt not_active IP Right Cessation
- 2008-12-05 EA EA201070691A patent/EA019616B1/ru not_active IP Right Cessation
- 2008-12-05 US US12/745,334 patent/US8350048B2/en active Active
- 2008-12-05 NZ NZ585652A patent/NZ585652A/en not_active IP Right Cessation
- 2008-12-05 AR ARP080105313A patent/AR069595A1/es unknown
- 2008-12-05 EP EP08855867.1A patent/EP2235008B1/en active Active
- 2008-12-05 KR KR1020107013595A patent/KR101624675B1/ko not_active IP Right Cessation
- 2008-12-05 PE PE2008002023A patent/PE20091263A1/es not_active Application Discontinuation
- 2008-12-05 AU AU2008333165A patent/AU2008333165B2/en not_active Ceased
- 2008-12-05 AP AP2010005285A patent/AP2804A/xx active
- 2008-12-05 PA PA20088806801A patent/PA8806801A1/es unknown
- 2008-12-05 CN CN2008801182809A patent/CN101878210B/zh not_active Expired - Fee Related
- 2008-12-05 CL CL2008003639A patent/CL2008003639A1/es unknown
- 2008-12-05 UY UY31513A patent/UY31513A1/es unknown
- 2008-12-05 MX MX2010006166A patent/MX2010006166A/es active IP Right Grant
- 2008-12-05 MY MYPI20102496 patent/MY151005A/en unknown
- 2008-12-05 TW TW097147227A patent/TWI438202B/zh not_active IP Right Cessation
-
2010
- 2010-05-02 IL IL205489A patent/IL205489A/en not_active IP Right Cessation
- 2010-06-04 ZA ZA2010/04025A patent/ZA201004025B/en unknown
-
2011
- 2011-04-13 HK HK11103719.1A patent/HK1149553A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8806801A1 (es) | Compuestos de amida como refuerzos de antivirales | |
| CO6470845A2 (es) | Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales | |
| DOP2014000115A (es) | Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1 | |
| CL2017002792A1 (es) | Derivados de ciclohexano sustituido con amido | |
| PA8841901A1 (es) | Compuestos orgánicos | |
| CL2017001191A1 (es) | Compuestos derivados de carbamoilpiridona policíclicos; composición farmacéutica que los comprende; y su uso para el tratamiento de una infección de vih en un humano que tiene o se encuentra en riesgo de tener la infección. | |
| GT201400111A (es) | Triazolopiridinas sustituidas | |
| UY32611A (es) | Compuestos de 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
| GT201200334A (es) | Morfolinopirimidinas y su uso en terapia | |
| UY32728A (es) | Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia | |
| GT201300254A (es) | Triazolopiridinas | |
| ECSP12012318A (es) | Inhibidores de pirazolil quinazolina cinasa | |
| BRPI0910388A2 (pt) | agentes terapêutico antivirais. | |
| HN2011001593A (es) | Piridiloxi-indoles del vegf-r2 y uso de los mismos para el tratmiento de enfermedades | |
| ECSP11011390A (es) | Compuestos espiro-amidas sustituidas | |
| CR20120264A (es) | Compuestos | |
| UY32426A (es) | Derivados bicilicos para uso en el tratamiento de enfermedades relacionadas al receptor de androgeno | |
| CO6640327A2 (es) | Compuestos de pirazol como inhibidores del receptor sigma | |
| DOP2015000076A (es) | Benzamidas | |
| UY31922A (es) | Compuestos | |
| UY32673A (es) | Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos | |
| UY31905A (es) | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
| BR112012009310A2 (pt) | composto, e, composição farmacêutica | |
| CO6321288A2 (es) | Sales de compuestos inhibidores de vih | |
| PA8793101A1 (es) | Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica |